Phensuximide
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 1-methyl-3-phenyl-pyrrolidine-2,5-dione | |
| Clinical data | |
| MedlinePlus | a682237 |
| Pregnancy cat. | ? |
| Legal status | ? |
| Pharmacokinetic data | |
| Protein binding | 21% |
| Identifiers | |
| CAS number | 86-34-0 |
| ATC code | N03AD02 |
| PubChem | CID 6839 |
| DrugBank | DB00832 |
| ChemSpider | 6578 |
| UNII | 6WVL9C355G |
| KEGG | D00508 |
| ChEMBL | CHEMBL797 |
| Chemical data | |
| Formula | C11H11NO2 |
| Mol. mass | 189.211 g/mol |
|
|
|
|
| |
Phensuximide is an anticonvulsant in the succinimide class.
[edit] Chemistry
Phensuximide, 1-methyl-3-phenylpyrrolidine-2,5-dione is synthesized by the reaction of phenylsuccinic acid or its anhydride with methylamine. ![]()
- C.A. Miller, L.M. Long, U.S. Patent 2,643,258 (1953).
- Miller, C. A.; Long, L. M. (1951). Journal of the American Chemical Society 73 (10): 4895. doi:10.1021/ja01154a126.
[edit] External links
- DDB 31648
- Rankin G, Cressey-Veneziano K, Wang R, Brown P (1986). "Urinary tract effects of phensuximide in the Sprague-Dawley and Fischer 344 rat.". J Appl Toxicol 6 (5): 349–56. doi:10.1002/jat.2550060509. PMID 3772011.
| This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
|

